(WHDH) — The Food and Drug Administration has approved a first-of-its-kind medical device that treats childhood ADHD.
The Monarch External Trigeminal Nerve Stimulation System is worn by children between the ages of 7 and 12, who are not currently on medication for ADHD, while they sleep.
A small adhesive patch is placed on the child’s forehead and delivers a low-level electrical pulse to the parts of the brain responsible for ADHD symptoms.
The device has also been investigated as a possible treatment for traumatic brain injury in veterans.
(Copyright (c) 2024 Sunbeam Television. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.)